The Incidence and Prevalence of Multiple Sclerosis in Nova Scotia, Canada

@article{Marrie2013TheIA,
  title={The Incidence and Prevalence of Multiple Sclerosis in Nova Scotia, Canada},
  author={Ruth Ann Marrie and John D Fisk and Karen Stadnyk and Bo Nancy Yu and Helen Tremlett and Christina Wolfson and S A Warren and Virender Bhan},
  journal={Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques},
  year={2013},
  volume={40},
  pages={824 - 831}
}
  • R. Marrie, J. Fisk, +5 authors V. Bhan
  • Published 2013
  • Medicine
  • Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques
Background: Estimates of incidence and prevalence are needed to determine disease risk and to plan for health service needs. Although the province of Nova Scotia, Canada is located in a region considered to have a high prevalence of multiple sclerosis (MS), epidemiologic data are limited. Objective: We aimed to validate an administrative case definition for MS and to use this to estimate the incidence and prevalence of MS in Nova Scotia. Methods: We used provincial administrative claims data to… Expand
Establishing the Incidence and Prevalence of Multiple Sclerosis in Saskatchewan
TLDR
S Saskatchewan has one of the highest rates of MS in the world and the first province-wide estimates of MS incidence and prevalence for Saskatchewan, Canada is provided. Expand
Incidence and prevalence of MS in children
TLDR
Administrative data provide a feasible, valid means of estimating the incidence and prevalence of MS in the pediatric population for Ontario, Canada, and MS prevalence in the Ontario pediatric population is among the highest reported in pediatric populations worldwide. Expand
Lower prevalence of multiple sclerosis in First Nations Canadians
TLDR
The incidence and prevalence of multiple sclerosis are twofold lower in the FN population than the non-FN population, but the prevalence of MS in FN Manitobans is higher than in other indigenous populations outside Canada. Expand
Incidence and prevalence of multiple sclerosis in Hungary based on record linkage of nationwide multiple healthcare administrative data
TLDR
The prevalence of MS in Hungary is higher than previously reported, the incidence rate is moderate, and the proportion of patients receiving disease modifying treatment grows but was still around 30% in 2015. Expand
Temporal trends in multiple sclerosis prevalence and incidence in a large population
TLDR
A spike in incidence in 2010 among younger patients and men at a time of widespread media coverage of MS suggests that these groups may be vulnerable to delayed diagnosis, and prevalence showed no consistent association with latitude. Expand
High incidence and increasing prevalence of multiple sclerosis in British Columbia, Canada: findings from over two decades (1991–2010)
TLDR
The prevalence and prevalence sex ratio of multiple sclerosis in British Columbia increased significantly during the 18-year period, which may be explained by the increased peak prevalence age of MS, longer survival with MS and the greater life expectancy of women compared to men. Expand
Performance of administrative case definitions for comorbidity in multiple sclerosis in Manitoba and Nova Scotia.
TLDR
Administrative case definitions for commonly observed comorbidities in MS performed well in 2 distinct jurisdictions, suggesting that they could be used more broadly across Canada and in national studies. Expand
Incidence of multiple sclerosis in the Republic of Ireland: A prospective population-based study.
TLDR
This is the first study to prospectively assess the incidence rate of MS in Ireland and shows that Ireland has a high incidence rate, comparable with the rest of the British Isles, with a persistent North-South gradient. Expand
Differing trends in the incidence of vascular comorbidity in MS and the general population
TLDR
The incidence rates of diabetes, hypertension, and hyperlipidemia are rising within the multiple sclerosis population, and programs to systematically prevent and treat these conditions are needed. Expand
Chronic lung disease and multiple sclerosis: Incidence, prevalence, and temporal trends.
TLDR
The incidence of CLD has been stable over time, but the prevalence has increased, and among persons aged 20-44 years, CLD is more common in the MS population than in a matched population. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 35 REFERENCES
The rising prevalence and changing age distribution of multiple sclerosis in Manitoba
TLDR
The use of administrative data to develop case definitions and further define the epidemiology of MS in Manitoba is supported, suggesting the rising prevalence with minimally changing incidence suggests improving survival. Expand
Incidence and prevalence of multiple sclerosis in Saskatoon, Saskatchewan
TLDR
The incidence study confirms the high risk of multiple sclerosis in Saskatoon and these rates seem to be stable over the past 35 years, and the high crude prevalence rate results from an accumulation of incidence and nonresident cases over time. Expand
Trends in prevalence and incidence of multiple sclerosis in Bajo Aragón, Spain
TLDR
The increase in prevalence of MS is more likely to be due to improvement on case ascertainment than to increasing incidence, and further prospective incidence studies in larger populations are warranted in Spain to elucidate whether the frequency of this disease is truly increasing. Expand
Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic Review
TLDR
There is a need for future studies of MS prevalence and incidence to include uniform case definitions, employ comparable methods of ascertainment, report standardized results, and be performed on a national level, as well as the inconsistencies in methodologies and quality among the published studies. Expand
Regional variation of multiple sclerosis prevalence in Canada
TLDR
Results suggest that Canadian MS prevalence differs by region, and if validated, these regional differences may facilitate investigation of environmental influences. Expand
Incidence and Prevalence of Multiple Sclerosis in Newfoundland and Labrador
TLDR
The increase in incidence and prevalence of multiple sclerosis in Newfoundland and Labrador is accounted for through both better access to diagnostic facilities and more practicing neurologists, more in keeping with recently reported values throughout Canada. Expand
Temporal trends in the incidence of multiple sclerosis
TLDR
The latitude gradient present in older incidence studies of multiple sclerosis (MS) is decreasing and the female-to-male MS ratio has increased in the last five decades. Expand
National estimate of multiple sclerosis incidence in France (2001–2007)
TLDR
The notification rate for multiple sclerosis in France was higher in north-eastern France, and lower on the Atlantic coast and in the Alps as well as on both sides of the Rhône River. Expand
Contribution of incidence to increasing prevalence of multiple sclerosis in Alberta, Canada
TLDR
The 2004 Alberta MS prevalence rate remains among the highest reported worldwide, and both increasing incidence and longer duration have likely contributed to increasing MS prevalence in the province. Expand
Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia
TLDR
Administrative data are a valid means of tracking diabetes, hypertension, and hyperlipidemia in multiple sclerosis and the prevalence of these comorbidities is similar in the MS and general populations. Expand
...
1
2
3
4
...